Quality Lead, EM CHC ASEA & AU
新加坡, 新加坡 Permanent Posted on Jan. 10, 2025 Closing on Feb. 28, 2025- Position: Quality Lead, EM CHC ASEA & AU
- Reporting to: Head of Quality, External Manufacturing CHC AMEA & China
- Location: Singapore
Opella, the Consumer Healthcare business unit of Sanofi, is the purest and third-largest player globally in the Over-The-Counter (OTC) & Vitamins, Minerals & Supplements (VMS) market.
We have an unshakable belief in the power of self-care and the role it can play in creating a healthier society and a healthier planet.
That’s why we want to make self-care as simple as it should be by being consumer-led always, with science at our core.
Through our unique and balanced portfolio of more than 100 loved brands, including 15 global and local high-growth challengers such as Allegra, Dulcolax and Buscopan, we deliver our mission: helping more than half a billion consumers worldwide take their health in their hands.
This mission is brought to life by an 11,000-strong team, 13 best-in-class manufacturing sites, and 4 specialized science and innovation development centers.
We are also proud to be the first major fast-moving consumer healthcare company to achieve B Corp certification.
Join us on our mission. Health. In your hands.
The QUALITY LEAD, EM CHC ASEA & AU shall manage the quality and compliance oversight of Contract Manufacturing Organisations (CMOs), third-party manufacturers and suppliers within the EM CHC ASEA & AU entity according to the GxP requirements, international, and Company global quality requirements.
The QUALITY LEAD, EM CHC ASEA & AU shall serve as the functional quality representative and ensure that CMOs / third party /suppliers are approved and that contracted Good Manufacturing Practices (GMP) activities are in compliance with international and local regulatory requirements, quality agreement, the registered dossier, and Company global quality documents when applicable.
The QUALITY LEAD, EM CHC ASEA & AU shall ensure regular monitoring, assessment of records and results related to the contracted GMP activities. The QUALITY LEAD, EM CHC ASEA & AU shall contribute to business operation by establishing partnerships and establishing trust with the CMOs / third party /supplier business partners and providing quality oversight and support for quality operations activities. The QUALITY LEAD, EM CHC ASEA & AU shall escalate activities, issues, progress to Head of Quality, EM CHC AMEA & China.
The QUALITY LEAD, EM CHC ASEA & AU shall assist in the establishment and continuous development of a robust Quality System of an appropriate standard and shall lead the key areas of Quality Assurance as applicable for the EM CHC AMEA – ASEA & AU entity in collaboration with the Quality Excellence Manager, EM CHC AMEA & China.
The QUALITY LEAD, EM CHC ASEA & AU will plan, organise and coordinate their workload and that of their Quality team members within the EM CHC ASEA & AU hub, so as to ensure that all routine scheduled work is carried out in a cost-effective and timely manner to GxP and regulatory guidelines and to Company procedures. The QUALITY LEAD, EM CHC ASEA & AU will have responsibility to ensure that their EM CHC ASEA & AU hub meets Quality Key Performance Indicators, in line with Organisational and Regulatory Standards and will take part in Quality and Regulatory Audits if required.
The QUALITY LEAD, EM CHC ASEA & AU shall participate in and manage the Quality observations and Self-inspection program for the EM CHC ASEA & AU hub with a key focus on continuous improvement and efficient compliance. The QUALITY LEAD, EM CHC ASEA & AU shall facilitate the empowerment of the EM CHC ASEA & AU hub Quality team members for operational quality decision making, without compromising the Quality System &/or Standards through implementation and adherence of the Quality Documentation, Quality Systems Management and Quality Technical Support.
The QUALITY LEAD, EM CHC ASEA & AU will collaborate across the full EM CHC AMEA & China entity to assist and support leadership and Quality workload as required to drive continuous improvement and efficient compliance.
Key Priorities:
1. Quality Management of third-party manufacturers and suppliers
- Manage the Quality Due diligence, evaluation, selection, and approval of third-party Contract manufacturers (CMO).
- Provide Quality oversight and quality support to Company entities managing third party manufacturers in this region.
- Manage the third-party audit plan for the EM CHC ASEA & AU hub and request / allocate / perform the GxP audits per plan.
- Manage the review, discussion, and follow-up of CAPAs related to audits performed and to the ongoing management of products manufactured by the third-party for the Company.
- EM CHC ASEA & AU Complaints management with review of complaints investigation, CAPA plan and effectiveness review. Monitoring of complaints trend and initiating CAPA where required.
- Management and support of product recall and return associated with EM CHC ASEA & AU.
- EM CHC ASEA & AU Change control management. Review, perform impact assessment, risk assessment and coordinate change control process. Monitoring of change controls trend.
- EM CHC ASEA & AU Deviation management and out-of-specification investigation. Review major / critical deviations, OOS investigations, CAPA plan and effectiveness review. Monitoring of deviations / OOS / CAPAs trends.
- Product Quality Review (PQR) evaluation of the PQR’s issued by CMOs for products managed by EM CHC ASEA & AU.
- Manage Quality aspects associated with termination activities with third-party manufacturers.
- Monitors and reports Quality KPIs. (Complaints, PQR, audit adherence to plan).
- Management of Quality Monitoring and Quality Review.
- Coordinate and participate in quality monitoring and quality review of third-party manufacturers.
- Coordinate and Perform risk ranking of third-party manufacturers.
2. Quality Operations of EM CHC ASEA & AU Entity
- Manage and participate in continuous improvement / development of quality systems on an ongoing basis and assist in investigations, reviews, management, and co-ordination of Quality Systems and processes within the EM CHC ASEA & AU entity and in collaboration with the Quality teams in full EM CHC AMEA & China entity, in line with Organisational, Global Quality, Regulatory Standards and Industry Best Practice.
- Manage the Quality documentation system, documentation retention, archival and destruction within the EM CHC ASEA & AU entity.
- Ensures the QMS processes and Quality documents understanding and appropriate execution by organization related personnel within EM CHC ASEA & AU entity.
- Ensures their appropriate evolution with regulations and business needs.
- Participate in and manage the Quality observations and Self-inspection program for the EM CHC ASEA & AU hub with a key focus on continuous improvement and efficient compliance.
- Manage and facilitate the empowerment of the EM CHC ASEA & AU hub Quality managers / team members for operational quality decision making, without compromising the Quality System &/or Standards through implementation and adherence to and alignment with the Quality Documentation, Quality Systems Management and Quality Technical Support.
- Manage and support the Quality Risk management in case of major / critical quality issue originating from third party manufacturers and raised by EM CHC ASEA & AU.
- Coordinate and participate in quality risk meetings and prepare rapid quality notifications if required.
- Quality business process owner for the EM CHC ASEA & AU entity to manage and collaborate on new requirements, new Quality System projects (as example new computerised systems), gaps to existing and procedural updates.
- Collect, consolidate, and prepare the quality KPI’s (Key Performance Indicators) for EM CHC ASEA & AU entity Monthly Quality Reports for reporting to regional Quality and EM CHC AMEA.
3. Quality Training
- Manage the electronic Learning Management system to support EM CHC ASEA & AU hub in conjunction with EM CHC AMEA Quality Excellence Manager
- Defines the GxP related personnel training curricula, and monitors execution of the GxP annual training plan, consolidation of training needs, development of training materials for the EM CHC ASEA & AU entity.
- Tracks compliance of the quality personnel (if applicable) and other applicable personnel members within the EM CHC ASEA & AU hub to their curricula. Ensures that training records are archived as per GxP regulation.
- Contributes to the EM CHC AMEA Awareness on GxP regulation and Quality requirements with respect to EM CHC ASEA & AU.
4. Quality Technical Support
- Contribute to the cross-functional working relationships of the team by participating in interactions between the EM CHC ASEA & AU Quality team and key stakeholders including, Innovation, External contractors and third-parties, Health & Safety, R&D, Regulatory CMC etc.
- Assist in investigations, reviews, management, and co-ordination of Quality Systems within the EM CHC ASEA & AU entity and provide quality oversight and support to third party manufacturers.
- Provide Technical advice and expertise with respect to product, CMO and quality system compliance.
- Manage and monitor completion to target of Annual Product Quality Review program across the EM CHC ASEA & AU entity.
- Manage and monitor the Change Control process for the EM CHC ASEA & AU hub, with associated filing in line with regulatory standards and organisational requirements if required.
- Manage the review of technical reports e.g. stability reports, process /process validation, transport qualification reports etc.
- Manage the collection, review and update of the Quality and Safety of Material and Product (QSMP) questionnaire and information from the third parties managed by the EM CHC ASEA & AU entity.
- Provide Quality support for transversal projects e.g. new product launch, site transfer or repatriation etc. as required
- Any Ad Hoc activities as specified by the Reporting Manager
追寻 发展。探索 菲凡。
进步需要我们每个人的参与——不论其背景、地域、或职业,我们都有一个共同的愿望:创造奇迹。你也可以成为其中的一员。我们不断追求变革,拥抱新思想,探索我们所能提供的一切机会。让我们一起追求进步。共同发现非凡。
在赛诺菲,不分种族、肤色、血统、宗教、性别、国籍、性取向、年龄、公民身份、婚姻状况、残疾或性别认同,我们为所有人提供平等的机会。
观看 “在赛诺菲的一天” ,并在官网 (sanofi.com) 上查看赛诺菲的多元化、公平与包容倡议!
查看所有职
我们的产品设计师负责帮助人们提高免疫力,物流专家负责将药物送到需要的人手中,而数据分析师则借助先进的技术改善人们的生活。在医疗健康领域,每一次进步都离不开所有人的努力。您可以自由选择自己的职业发展道路。Gig零工项目将帮助您尝试更多岗位,个性化指导将为您挖掘自己从未被发现的优势。加入我们,开启菲凡的职业发展之路。您到底可以走多远?让我们拭目以待!
体验可能性
-
Ama
Ama puts her project management techniques and ServiceNow knowledge to use to help advance Sanofi’s Digital Data operating model. Learn how our team connects data and AI to do what’s never been done before.
-
Cambridge Crossing
We're bringing together 2,500 people from across our organization — R&D, Medical, Commercial and Global colleagues all working to realize the power of collaboration.
-
Innovation in Action
Our flexible lab of the future will transform how we conduct research, while our innovation center will be fully integrated with existing R&D locations.
-
Sanofi’s AI Centre of Excellence in Toronto
The Centre is focused on using leading technologies to develop world-class data and artificial intelligence (AI) products to create value for the health sector.
-
Sanofi Canada's Philanthropic Efforts
By chasing the miracles of science to improve people’s lives, we surprise ourselves with what we can achieve. Our team is humbled by the impact our efforts make.
-
Sustainable and Green
Our new facility was built to minimize the environmental impact — helping protect our planet and people. Using resources efficiently, we're providing greener, healthier workspaces.
-
-
-
我们的办公地点
我们的员工遍布60多个国家/地区。他们勠力同心,携手共创医疗健康领域的美好未来。无论您在哪里工作,我们的专家都会指导您推动职业发展,您也将能够运用先进的科学技术,取得意义非凡的重大突破。
-
勇敢追梦,奔赴美好未来
想要改变自己的生活,乃至改变全球数百万人的生活,该怎么做?加入我们,开启职业新篇章,然后在我们的保驾护航中展翅高飞,并向优秀的人求教,为这份事业做出切实的贡献。
-
您和我们相互依存,共同成长
我们精心打造薪酬体系,为您的身心健康、财务健康与社交健康提供全面保障。我们有着海纳百川的包容性团队文化,无论您在哪个岗位,都能展翅高飞。
-
心怀梦想,成就一番事业
我们希望您以饱满的热情投入到自己的工作岗位中,给全球数百万人带来美好生活。您的职业发展道路由您自己来掌控。您只管制定目标,我们会提供充足的培训机会和支持,让您得偿所愿。
-
我们的人与文化
我们是首个建立多元化、公平性和包容性(DE&I)委员会的制药企业。我们还建立了“菲常联盟”,为每位员工提供发声的平台。您的声音是我们建设未来道路的重要基石。
-
我们的故事
我们关注每一个员工的声音。因为,我们的未来取决于所有员工的付出与努力。正因为他们的助力,我们才能追求远大的理想。
-
为什么选择我们?
我们为您提供各种工具、支持和培训机会,帮助您实现自己的目标。我们也希望您充分发挥潜力,帮助我们实现目标:将新药研发到临床治疗的时间减半。